Novel Model for South Asian Treatment in Diabetes (NaMaSTe-Diabetes) Trial in Primary Care (Namaste)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02136654 |
Recruitment Status :
Recruiting
First Posted : May 13, 2014
Last Update Posted : November 27, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Type 2 Diabetes Mellitus | Behavioral: Culturally tailored diabetes program | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 600 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Health Services Research |
Official Title: | Novel Model for South Asian Treatment in Diabetes (NaMaSTe-Diabetes) Trial in Primary Care |
Study Start Date : | July 2015 |
Estimated Primary Completion Date : | December 2021 |
Estimated Study Completion Date : | December 2021 |

Arm | Intervention/treatment |
---|---|
Experimental: Culturally tailored diabetes program
Culturally tailored diabetes program
|
Behavioral: Culturally tailored diabetes program
Includes family member and peer support Includes communication training |
No Intervention: Usual Care
Usual Care includes continuing to visit primary care physician for ongoing diabetes management Printed diabetes education materials.
|
- Change in A1C or blood pressure (systolic or diastolic blood pressure) [ Time Frame: within 6 months from baseline; 0, 3, and 6 months ]
- change in fasting lipid profile [ Time Frame: 6 months; 0 and 6 months ]
- Change in weight or waist circumference [ Time Frame: 6 months; 0, 3, and 6 months ]
- change in health status [ Time Frame: 6 months; 0, 3, and 6 months ]
- Procedure related outcomes [ Time Frame: 6 months; 0, 3, and 6 months ]health behaviours, medication adherence, patient engagement/activation, diabetes management, diabetes distress, depression, social support, knowledge, motivation, self efficacy.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- age >19 years of age
- type 2 diabetes mellitus requiring at least one medication (oral hypoglycemic agent and/or insulin) to control diabetes
- A1C ≥7% in past 1 year
- willingness/ability to attend the Diabetes education, dietician, and peer sessions and follow up assessments
- ability to provide informed consent
- self identify as South Asian (from India, Pakistan, Sri Lanka, or Bangladesh) regardless of generational status or timing of immigration with ability to speak in English or Punjabi.
Exclusion Criteria:
- life- limiting illness <12 months
- physical inability to exercise
- recurrent severe hypoglycemia or hypoglycaemic unawareness
- family member of, or living in same household as a participant
- pregnancy or gestational diabetes.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02136654
Contact: Gurpreet Oshan, BA | 778 387 3100 | gurpreetoshan@gmail.com | |
Contact: Nadia A Khan, MD MSc | 604 682 2344 ext 63657 | nakhanubc@gmail.com |
Canada, British Columbia | |
University of British Columbia | Recruiting |
Vancouver, British Columbia, Canada, V6Z 1Y6 | |
Contact: Gurpreet Oshan, BA 778 387 3100 | |
Contact: Nadia Khan, MD nakhanubc@gmail.com | |
Principal Investigator: Nadia Khan, MD | |
Principal Investigator: Tricia Tang, PhD |
Principal Investigator: | Nadia A Khan, MD MSc | University of British Columbia | |
Principal Investigator: | Tricia Tang, PhD | University pf British Columbia |
Responsible Party: | Khan, Professor, University of British Columbia |
ClinicalTrials.gov Identifier: | NCT02136654 |
Other Study ID Numbers: |
H14-00693 |
First Posted: | May 13, 2014 Key Record Dates |
Last Update Posted: | November 27, 2020 |
Last Verified: | November 2020 |
diabetes ethnicity South Asian diabetes management |
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |